Literature DB >> 27422758

Prognostic clinical factors associated with remission and relapse in bullous pemphigoid.

J H Lee1, T H Kim1, S H Park1, K Han1,2, S-C Kim1.   

Abstract

BACKGROUND: Prognostic factors for remission and relapse of bullous pemphigoid (BP) remain uncertain.
OBJECTIVE: To evaluate clinical factors associated with remission and relapse in Korean patients with BP.
METHODS: A retrospective analysis was conducted of 174 patients diagnosed with BP between 1993 and 2014 at Gangnam Severance Hospital in Seoul, Korea.
RESULTS: Of the 174 identified patients, 131 (75.29%) achieved remission after a mean treatment duration of 393.69 days. Prognostic factors for remission were older age (≥70 years) and the absence of an admission history. Of 131 patients who achieved remission, 40 patients (30.53%) experienced relapse after a mean duration of 335.65 days. However, no statistically significant factors were predictive of relapse by multivariate analysis.
CONCLUSIONS: This study suggests BP patients who are older and have no admission history tend to achieve remission.
© 2016 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2016        PMID: 27422758     DOI: 10.1111/jdv.13839

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  1 in total

1.  High Index Values of Enzyme-Linked Immunosorbent Assay for BP180 at Baseline Predict Relapse in Patients With Bullous Pemphigoid.

Authors:  Hiroshi Koga; Kwesi Teye; Norito Ishii; Chika Ohata; Takekuni Nakama
Journal:  Front Med (Lausanne)       Date:  2018-05-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.